Recursion · Series C

Pioneering AI-driven solutions in drug discovery to radically improve lives.

Amount

$121M

Round

Series C

Valuation

—

Announced

Jul 2019

Investors

Lead investor

Scottish Mortgage Investment Trust (Baillie Gifford)

Participating investors

Lux Capital Obvious Ventures

Data Collective

Other Recursion rounds

Date	Round	Amount
Apr 2021	IPO	$436.4M	Details →
Sep 2020	Series D	$239M	Details →
May 2017	Series B	$60M	Details →